SANGTER Energy Supplement Capsules — Class I drug recall D-1333-2022
Terminated recall by Distributor RFR, LLC., reported 2022-08-10, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
| Recall number | D-1333-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Distributor RFR, LLC., Doral, FL, United States |
| Recall initiated | 2022-07-22 |
| Classified | 2022-08-09 |
| Reported by FDA | 2022-08-10 |
| Terminated | 2025-07-29 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, FR, VE |
| Quantity | 2,000 cartons |
| Reason classes | unapproved product |
| Lot numbers | 48656 |
| Expiration dates | 2025-01 |
Product
SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1333-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.